The process of chondrogenesis can be mimicked in vitro by insulin treatment of mouse ATDC5 chondroprogenitor cells. To identify novel factors that are involved in the control of chondrogenesis, we carried out a large-scale screening through retroviral insertion mutagenesis and isolated a fast-growing ATDC5 clone incapable of chondrogenic differentiation. Inverse-PCR analysis of this clone revealed that the retroviral DNA was inserted into the promoter region of mouse Id2 (inhibitor of DNA-binding protein 2) gene. This retroviral insertion increased Id2 protein levels to twice those found in normal ATDC5 cells. To investigate whether an elevated level of Id2 protein was responsible for inhibition of chondrogenic differentiation, ATDC5 cells were infected with a retrovirus to stably express Id2. ATDC5 cells expressing ectopic Id2 exhibited signs of de-differentiation, such as rapid growth, and insulin failed to induce expression of Sox9 (Sry-type highmobility-group box 9) or matrix genes such as type II collagen (COL2) in these cells. When endogenous Id2 was knocked down by siRNA (small interfering RNA) in ATDC5 cells, expression of Sox9 and COL2 was increased and chondrogenic differentiation was accelerated. To examine how Id2 is expressed in chondrocytes in vivo, we carried out immunostaining of E16.5 mouse embryos and found that Id2 is expressed in articular chondrocytes and proliferating chondrocytes, but barely detectable in hypertrophic chondrocytes. Our results suggest that proper expression of Id2 is important to achieving a fine balance between growth and differentiation during chondrogenesis.
INTRODUCTION
Endochondral bone formation involves condensation of mesenchymal cells and their subsequent differentiation into mature chondrocytes that express type II collagen (COL2). In the centre of this rudimentary bone, mature chondrocytes can further differentiate into hypertrophic chondrocytes. These hypertrophic cells express type X collagen (COLX) and mineralize the surrounding matrix before undergoing apoptosis. The cartilage matrix left behind then provides a scaffold for growth of osteoblasts/ osteoclasts along with other cells that comprise mature bone [1] .
The process of chondrocyte differentiation can be mimicked in vitro by insulin treatment of the mouse ATDC5 chondroprogenitor cells [2] . After insulin stimulation, these cells condense to form nodules and synthesize cartilage-like extracellular matrix (ECM) that stains positive with Alcian Blue. After prolonged culture in insulin medium, these cells initiate the synthesis of COLX and eventually die by apoptosis. To identify novel factors that are involved in the control of chondrogenesis, we carried out a large-scale screening through random retroviral integration into the genome of ATDC5 cells. If these random insertions disrupt genes that are critical to the control of chondrogenesis, the end result could be spontaneous chondrogenic differentiation of ATDC5 cells in the absence of insulin, on one hand, or blockage of chondrogenic differentiation of ATDC5 cells in the presence of insulin on the other. As these mutant ATDC5 clones can be isolated via Alcian Blue staining, identification of the corresponding retroviral integration sites (and the likely affected genes) within the ATDC5 genome will add to our understanding of the complex network that regulates chondrogenesis.
In the present study, we report the results of our random mutagenesis screening and the characterization of a fast-growing ATDC5 clone that has lost the ability to undergo chondrogenic differentiation. Sequencing of the retroviral insertion site in this clone revealed that the insertion is located within the promoter region of the Id2 (inhibitor of DNA-binding protein 2) gene, which in turn led us to investigate the inhibitory effects of elevated Id2 expression on chondrocyte differentiation. Id2 is a member of the Id family of proteins that have a helixloop-helix (HLH) domain but lack a DNA-binding domain [3, 4] . Id proteins act as dominant-negative antagonists of the basic HLH transcription factors through the formation of 'nonfunctional' Id-basic HLH heterodimers [5, 6] . Id2 is known to be involved in the differentiation of osteoblasts/osteoclasts and represents a downstream target of bone morphogenetic protein and transforming growth factor β (TGFβ) during osteogenesis [7] . Knockout of the Id2 gene in mice causes retarded growth [8] . Our study, for the first time, demonstrates that overexpression of Id2 may cause de-differentiation of ATDC cells and blockage of insulin-induced chondrogenic differentiation, whereas siRNA (small interfering RNA) knockdown of Id2 can accelerate the differentiation of ATDC5 cells. In vivo, the level of Id2 protein is inversely correlated with the status of terminal differentiation among growth plate chondrocytes. These results suggest that a subtle change in Id2 expression during chondrogenesis may have a big impact on the balance between growth and differentiation of chondrogenic cells.
MATERIALS AND METHODS
Cell culture and Alcian Blue staining ATDC5 cells, a chondrogenic cell line derived from mouse embryonal carcinoma [2] , were cultured in a 1:1 mixture of Dulbecco's modified Eagle's medium and Ham's F-12 (Cambrex Bio Science Inc, Walkersville, MD, U.S.A.) supplemented with 2 % FBS (Invitrogen Co., Carlsbad, CA, U.S.A.), 10 μg/ml human transferrin (Sigma-Aldrich Co., St. Louis, MO), 3×10 − 8 M sodium selenite (Sigma-Aldrich Co.) at 37
• C under 5 % CO 2 . After cells reached confluence, they were stimulated with 10 μg/ml bovine insulin (Sigma-Aldrich Co.), and the media was changed every other day. For counting of viable cells during differentiation, ATDC5 cells were seeded in 24-well multiplates at a density of 2×10 5 cells/well on day 0. Viable cells were trypsinized and counted in triplicate in 0.5 % Trypan Blue solution.
Alcian Blue (Sigma-Aldrich Co.), which stains the cartilagelike ECM produced by mature chondrocytes, was used to evaluate expression of ECM by ATDC5 cells. For the staining, cells in each well were rinsed with PBS, incubated with 0.2 % Alcian Blue solution in 0.1 M HCl (pH 1.0) overnight, and washed three times with PBS before macroscopic examination.
Extraction of RNA and reverse transcriptase (RT)-PCR
Total RNA was extracted from 5×10 5 ATDC5 cells using the RNeasy Mini Kit (Qiagen, Valencia, CA, U.S.A.) and eluted in 40 μl of water. For RT-PCR, 2 μl of RNA was analysed in a total volume of 25 μl using the SuperScript One-Step RT-PCR Kit (Invitrogen). The primers for mouse COL2 mRNA were 5 -CAG GCC TCG CGG TGA GCC ATG AT-3 (sense) and 5 -GTT CTC CAT CTC TGC CAC G-3 (anti-sense). The primers for mouse COLX mRNA were 5 -CAG AGG AAG CCA GGA AAG C-3 (sense) and 5 -GGT GTC CAG GAC TTC CAT AGC-3 (anti-sense). The primers for mouse glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were 5 -GTG GAT ATT GTT GCC ATC ATT-3 (sense) and 5 -TGA TGG CAA CAA TAT CCA CTT-3 (anti-sense). The primers for mouse Id2 cDNA were 5 -CGC TCT AGA AGC AGC ATG AAA GCC TTC-3 (sense) and 5 -GCC GGA TCC ATT TAT TTA GCC ACA GAG-3 (antisense).
Plasmid constructs
Full-length mouse Id2 cDNA was amplified from ATDC5 cells by RT-PCR. The amplified cDNA was then cloned into the XbaIBamHI sites of the pCG vector [9] which tags the N-terminal end of Id2 protein with a T7 epitope. For LXSN retroviral construct expressing T7-tagged Id2, T7-Id2 cDNA was amplified by PCR and cloned into the EcoRI-BamHI sites of pLXSN retroviral vector (Clontech Laboratories, Inc., Mountain View, CA, U.S.A.).
Retroviral infection
Retrovirus was generated through calcium phosphate transfection of the PT67 packaging cells with LXSN retroviral constructs. The virus-infected ATDC5 cells were selected with G418 at 0.5 mg/ml for stable integration. G418-resistant single clones were picked individually and expanded in triplicate 96-well plates. After reaching confluence, cells in one plate were stimulated with insulin at a final concentration of 10 μg/ml. After 3 weeks, cells in the insulin-stimulated plate as well as one un-stimulated plate were stained with 0.2 % Alcian Blue. Individual T7-Id2 expressing clones were isolated similarly and protein expression was confirmed by Western blotting with a monoclonal anti-T7 antibody.
Inverse-PCR analysis of retroviral integration sites
Genomic DNAs were isolated from ATDC5 clones of interest. Genomic DNA (5 μg) was digested with BamHI and the digested DNAs were then circularized with T4 DNA ligase. DNA fragments containing the retroviral insertion sites were amplified using the Long Template-PCR kit (Roche Molecular Biochemicals, Indianapolis, IN, U.S.A.) with primers NEO-U3 (5 -AGC GCA TCG CCT TCT ATC-3 ) and NEO-D3 (5 -CCA GTC ATA GCC GAA TAG-3 ). The amplified DNAs were isolated and sequenced using primer NEO-U5 (5 -AGA GAA CCA TCA GAT GTT-3 ). The mouse genomic sequences identified at the sites of retroviral insertion were then BLAST searched against the mouse genome database in the GenBank ® to locate the affected genes, as described previously [10] .
Lentivirus-mediated siRNA knockdown
Lentiviral siRNA constructs were obtained by annealing the predesigned primers and subsequent cloning into the HpaI-XhoI sites of the pLL3.7 lentiviral vector [11] For lentivirus generation, 293FT packaging cells were transfected with 6 μg of a pLL3.7-siRNA construct plus 9 μg of ViraPower DNA Mixture (Invitrogen) by the Lipofectamine ® 2000 method according to the manufacturer's instructions. After 48 h, supernatants containing lentivirus were collected and used to infect ATDC5 cells in the presence of 6 μg/ml polybrene. Infected GFP-positive cells were first enriched by sorting by flow cytometry then expanded for further analysis.
Western blot analysis
To confirm retroviral expression of T7-Id2 protein, 2×10 6 ATDC5 cells were collected and lysed with 0.1 ml of Buffer X [50 mM Tris (pH 7.4), 270 mM NaCl, 0.5 % Triton X-100] supplemented with protease and phosphatase inhibitors (Sigma-Aldrich Co). After separation on a SDS/2.5 %-(w/v)-PAGE gel and transferred onto a polyvinylidene difluoride membrane (Bio-Rad Laboratories, Hercules, CA, U.S.A.), the membrane was blotted with the horseradish peroxidase-conjugated mouse monoclonal anti-T7 antibody (EMD Biosciences, Inc., San Diego, CA, U.S.A.) or a rabbit polyclonal anti-Id2 (clone C-20; Santa Cruz Biotechnology, Santa Cruz, CA, U.S.A.). The protein band was visualized using the ECL Plus Western Blotting Detection Reagents (Amersham Biosciences Corp., Piscataway, NJ, U.S.A.). Expression of Sox9 (Sry-type high-mobility-group box 9) was similarly detected with a rabbit polyclonal antibody (Clone H-90; Santa Cruz Biotechnology) after separation by SDS/PAGE on an 8 % gel.
Immunohistostaining
Paraformaldehyde-fixed sections of E16.5 mouse embryos were de-paraffinized with xylene, rehydrated and blocked with 3 % normal goat serum for 2 h. The sections were then incubated with 1:200-diluted rabbit polyclonal anti-Id2 antibody (Santa Cruz Biotechnology) or control rabbit IgG at 4 • C overnight, followed by incubation with 1:200 diluted Cy3-conjugated goat anti-rabbit IgG (Jackson ImmunoResearch, West Grove, PA, U.S.A.) for 2 h. After 4 washes, the sections were mounted with VECTASHIELD mounting medium (Vector Laboratories, Inc., Burlingame, CA, U.S.A.) and examined under Nikon fluorescence microscope.
RESULTS

Retroviral insertion disrupts insulin-dependent chondrogenic differentiation of ATDC5 cells
The growth of mouse ATDC5 chondroprogenitor cells will normally slow down upon reaching confluence. However, when cultured in a medium containing insulin, confluent ATDC5 cells will condense to form nodules and start to undergo chondrogenic differentiation. This eventually leads to the production of a cartilage-like matrix that can be stained by Alcian Blue ( Figure 1A ; left panel). We noticed that when ATDC5 cells were first infected with a retrovirus and then cultured for 21 days, a few of the retrovirus-infected cells could form colonies that also stained positive with Alcian Blue, even in the absence of insulin ( Figure 1A ; right panel). As it is well-known that a retrovirus can randomly integrate into the genome of the host cells, we speculated that a small number of the retroviral integrations would integrate within genes critical to insulin-dependent chondrogenic differentiation of ATDC5 cells. Unscheduled activation or silencing of these critical genes could result in spontaneous chondrogenic differentiation of ATDC5 cells, leading to a phenotype of positive Alcian Blue stain, even in the absence of insulin. On the other hand, activation or silencing of these critical genes could also lead to blockage of chondrogenic differentiation, resulting in a phenotype of negative Alcian Blue stain, even in the presence of insulin.
To identify these critical genes that are affected by retroviral insertions, we transduced ATDC5 cells with a diluted retrovirus stock to favour infection of each cell by a single retroviral particle. Individual colonies with stable retroviral integration were then selected by G418 and screened in duplicate 96-well plates for their response to insulin stimulation through Alcian Blue staining. Out of 10×10 3 colonies examined, the vast majority were normal clones such as E22-4 and F2-3, which could differentiate in response to insulin ( Figure 1B , left two panels). A few colonies such as E22-5 showed spontaneous differentiation in the absence of insulin ( Figure 1B ; third panel). Several colonies, such as the one designated C15-6, did not stain with Alcian Blue even when cultured in insulin for 21 days ( Figure 1B ; far right panel). Therefore, a small number of the retroviral insertions resulted in deregulation of genes that are important to chondrogenic differentiation of ATDC5 cells.
Retroviral insertion increases Id2 expression in the differentiationdefective clone
To identify genes that are affected by retroviral insertions, we isolated genomic DNA from ATDC5 clones that either underwent spontaneous differentiation or failed to be induced by insulin. We then carried out inverse-PCR analysis to determine the exact location of the corresponding retroviral insertion on the genome. For inverse-PCR, the genomic DNA was digested with a 2) , a mutant clone E22-5 that underwent spontaneous differentiation (lane 3), and mutant clone C15-6 that was unable to differentiate (lane 4) were expanded and cultured in medium with or without insulin for 21 days, then stained with Alcian Blue. restriction enzyme that cuts only once within the retroviral vector, but cuts at multiple sites on the surrounding genomic DNA. The digested DNA fragments were then circularized with T4 ligase, and the circular DNA containing the insertion site was amplified by inverse-PCR using Neo (neomycin-resistant gene) primers that are unique to the retroviral vector. Agarose gel electrophoresis of inverse-PCR products using BamHI-digested genomic DNA from clone C15-6 generated a single band around 3.4 kb (Figure 2A) . Sequencing of this DNA fragment revealed that the site of retroviral insertion is located 0.8 kb upstream from the ATG translation start codon of the mouse Id2 gene. To ascertain that clone C15-6 carries a single provirus, its genomic DNA was digested with BamHI and blotted with a 32 P-labelled Neo probe. This Southern blotting detected a single band around 3.5 kb ( Figure 2B ), confirming that clone C15-6 only carries a single retroviral integration in its genome. Our additional sequencing revealed that the retroviral DNA is inserted in an anti-sense orientation to the Id2 gene ( Figure 2C ). As retroviral insertion in the anti-sense orientation usually results in up-regulation of its downstream gene, we compared the level of Id2 expression in clone C15-6 with ATDC5 cells and two normal clones (E22-4 and F2-3) through Western blotting. In comparison with ATDC5 cells or the two normal clones, Id2 protein levels in C15-6 were indeed increased as a result of the retroviral insertion. Serial dilution of C15-6 lysate revealed that the level of Id2 protein in C15-6 was approx. twice that found in ATDC5 cells ( Figure 2D) .
Inverse-PCR analysis of clone E22-5 revealed that the retrovirus is inserted into the promoter region of the TGF-β3 gene. The positive effects of TGF-β3 on chondrocyte differentiation have been well documented both in embryonic stem cells [12] and mesenchymal stem cells [13] . We therefore decided not to further pursue this clone.
Id2 protein promotes proliferation of ATDC5 cells
Upon reaching confluence, the proliferation of ATDC5 chondroprogenitor cells will slow down in the absence of insulin. Clone C15-6, in which the level of Id2 protein was elevated by retroviral insertion, appeared to acquire an ability to proliferate rapidly after confluence. To assess accurately the differences between clone C15-6 and the phenotypically normal clones E22-4 and F2-3, cells from these three clones were seeded into 24-well plates at an initial density of 2×10 5 cells/well in culture medium, with or without insulin. Cell numbers in the wells were counted every 2 days for a total of 8 days. In the absence of insulin, C15-6 and the two normal clones grew at a similar rate before reaching confluence at day 2. Subsequently, the proliferation of clone C15-6 accelerated, whereas the growth of the two normal clones remained steady ( Figure 3A ). Even though insulin was able to facilitate the proliferation of normal clone E22-4 and F2-3, it had less of an effect on the proliferation of the Id2 over-expressing clone C15-6 ( Figure 3B ). Thus, an increase in Id2 expression appears to confer an advantage in proliferation upon clone C15-6, while blocking chondrogenic differentiation.
Ectopic expression of Id2 promotes proliferation and blocks differentiation in ATDC5 cells
To confirm that a higher level of Id2 protein was indeed responsible for the phenotype changes observed in clone C15-6, we amplified the mouse Id2 cDNA by RT-PCR and cloned the cDNA into an LXSN retroviral vector for infection of ATDC5 cells. To differentiate the ectopic Id2 protein from the endogenous one, Id2 cDNA in the retroviral vector was tagged with a T7-epitope which can be easily detected by Western blotting. After retroviral infection, individual clones were isolated and expanded after G418 selection. For this study, we have focused on four representative clones: C-1, C-2, C-3 and C-5. Western blotting with an anti-T7 antibody showed that in clone C-1, expression of T7-Id2 was not detectable and therefore this clone was used as a negative control. Expression of T7-Id2 in clone C-5 was detectable but its level was lower than those in clone C-2 and C-3 ( Figure 4A ; top panel). Western blotting with an anti-Id2 antibody detected both ectopic T7-Id2 and endogenous Id2 proteins, and confirmed the relative levels of T7-Id2 in these clones ( Figure 4A ; middle panel). To investigate whether ectopic expression of T7-tagged Id2 could also inhibit chondrogenic differentiation of ATDC5 cells, these clones were cultured in medium with or without insulin for 21 days. Clone C-1, which did not express T7-Id2, was able to produce a cartilage-like matrix that stained positive with Alcian Blue. In contrast, the T7-Id2 expressing clones C-5, C-2, and C-3 failed to stain with Alcian Blue (results not shown). These results suggest that Id2 expression in chondroprogenitor cells, even when increased modestly, can have a significant negative impact on differentiation and production of cartilage-like matrix.
To investigate the effect of ectopic Id2 expression on proliferation, clones C-1, C-2, C-3 and C-5 were again seeded into 24-well plates at an initial density of 2×10 5 cells/well in culture medium with or without insulin. Cell numbers in the wells were counted every 2 days for a total of 6 days. Regardless of the presence or absence of insulin, the proliferation rate for clone C-1 was always the lowest, while the proliferation rate for clone C-5 was higher than C-1, but lower than C-2 and C-3 ( Figures 4B and 4C) . Since the rate of proliferation is dependent on the expression level of ectopic T7-Id2 in these clones, our results support the notion that Id2 protein promotes the proliferation of ATDC5 cells.
Id2 inhibits expression of COL2 in ATDC5 cells
The above experiments have demonstrated that both activation of endogenous Id2 gene (through retroviral insertion at the promoter) and expression of ectopic T7-Id2 (through retroviral transduction) both inhibited chondrogenic differentiation and production of cartilage-like matrix. A hallmark of chondrocyte differentiation is the expression of COL2, a major component of the cartilage generated by mature chondrocytes [14] . We speculated that since Id2 was able to inhibit chondrocyte differentiation, it might also have an inhibitory effect on the expression of the COL2 gene in ATDC5 cells.
To analyse changes in COL2 expression, we isolated total RNA from ATDC5 cells, from clone C15-6 (which had an elevated level of endogenous Id2 protein) as well as from normal clones E22-4 and F2-3. Alternative splicing of the COL2 pre-mRNA transcripts usually generates COL2A and COL2B splicing isoforms, the ratio of which changes during the differentiation of chondrocytes [15] . In ATDC5 cells and normal clones E22-4 and F2-3 cultured with insulin, expression of the COL2 gene was up-regulated with a concomitant COL2A→COL2B switch ( Figure 5A ; lanes 1-2 and 5-8). In contrast, insulin failed to induce COL2 expression in clone C15-6 ( Figure 5A; lanes 3-4) . Similarly, the control clone C-1 (which did not express ectopic T7-Id2) retained the ability to up-regulate COL2 expression and to switch splicing isoforms after 14-day insulin treatment (Figure 5B; lanes 1-2) , while clones C-5, C-2 and C-3 (which stably expressed ectopic T7-ID2) had lost such an ability ( Figure 5B; lanes 3-8) .
Insulin fails to induce Sox9 in Id2 over-expressing ATDC5 cells
How did over-expression of Id2 lead to the down-regulation of COL2 and a decrease in the amount of cartilage-like ECM? Expression of COL2 is known to be controlled by Sox9, a master regulator of chondrocyte differentiation. We therefore carried out Western blotting analysis to examine whether Sox9 expression is affected by Id2. In ATDC5 cells, Sox9 protein is expressed and its level was increased following insulin treatment ( Figure 5C; lanes 1-2) . Similarly, expression of Sox9 was increased by insulin treatment in normal clones E22-4 and F2-3 ( Figure 5C; lanes 5-8) . Surprisingly, the basal level of Sox9 was significantly higher in clone C15-6 (a clone that over-expresses endogenous Id2) than in ATDC5 cells or the two normal controls. Moreover, addition of insulin to the culture medium failed to upregulate Sox9 expression, but instead decreased its expression in clone C15-6 ( Figure 5C; lanes 3-4) . Expression of Sox9 was also examined in clones that express ectopic T7-tagged Id2. Again, in control clone C-1 that did not express T7-Id2, Sox9 protein was detectable in unstimulated cells and insulin treatment led to an increase in Sox9 ( Figure 5D; lanes 1-2) . Ectopic expression of T7-Id2 in ATDC5 clones C-5, C-2 and C-3 is associated with a higher level of Sox9 in the absence of insulin treatment. However, addition of insulin to the culture medium led to decreased expression of Sox9 in these T7-Id2 over-expressing clones ( Figure 5D; lanes 3-8) .
siRNA knockdown of Id2 facilitates chondrogenic differentiation of ATDC5 cells
We have shown the inhibitory effects of Id2 over-expression on chondrogenic differentiation in ATDC5 cells. To confirm further that these effects were real and not artifacts, we next used the pLL3.7 lentiviral vector to achieve stable and long-term siRNA knockdown of Id2. This lentiviral vector also co-expresses GFP, therefore the infection can be easily monitored by fluorescence microscopy. If the infection efficiency is not high enough, siRNAexpressing GFP-positive cells can also be enriched through sorting by flow cytometry. Using this lentiviral vector, we were able to obtain close to 100 % transduction efficiency in ATDC5 cells (results not shown). While expression of a scrambled siRNA did not affect Id2 expression in comparison with mock infected ATDC5 cells, stable expression of a specific siRNA was able to achieve near complete knockdown of Id2 when analysed by Western blotting ( Figure 6A ; top panel, compare lanes 1 and 2 with lane 3). In addition, Id2 down-regulation was accompanied by an increased level of Sox9 protein ( Figure 6A ; middle panel). These effects appear to be specific, as expression of the house-keeping gene β-actin was not affected by the lentivirus-delivered siRNA ( Figure 6A ; bottom panel). To examine the effects of Id2 knockdown on matrix genes such as COL2, lentivirus-infected cells were cultured in insulin-containing medium for 6 days and RNA samples were then prepared. When analysed by RT-PCR, COL2 mRNA levels were shown to be higher in cells with Id2 knockdown than in mock infected cells or cells with a scrambled siRNA ( Figure 6B ). This was further supported by our observation that ATDC5 cells expressing siRNA against Id2 formed more Alcian Blue-positive nodules than did cells that were either mock infected or expressing a scrambled siRNA ( Figure 6C ).
Id2 protein levels are inversely correlated with the status of terminal differentiation in ATDC5 cells and in growth-plate chondrocytes
To monitor how insulin treatment affects Id2 protein expression during chondrogenic differentiation of ATDC5 cells, we cultured the cells in insulin-containing medium for up to 35 days to ensure that some cells had entered into terminal differentiation and become hypertrophic chondrocytes. As shown by RT-PCR analysis, the splicing pattern of COL2 switched from COL2A to COL2B during the process ( Figure 7A ; top panel). Prolonged insulin treatment also led to expression of COLX ( Figure 7A ; middle panel), a hallmark of hypertrophic differentiation. Western blotting revealed that the level of Id2 protein was first elevated transiently with insulin treatment, peaking around day 14 after treatment. Id2 protein levels then gradually decreased as more cells entered into the stage of hypertrophic differentiation ( Figure 7B ; top panel). It should be noted that chondrogenic differentiation of these ATDC5 cells are not synchronized, and our Western blotting analysis may not reflect faithfully the levels of Id2 protein in individual hypertrophic cells. Sox9 expression is also elevated following insulin treatment of ATDC5 cells ( Figure 7B ; middle panel).
To investigate how expression of Id2 is truly correlated with chondrocyte differentiation in vivo, we carried out immunohistostaining of growth plate chondrocytes from E16.5 mouse embryos. As shown in Figure 8 , Id2 protein is most abundant in articular chondrocytes and proliferating chondrocytes near the joint. However, its level decreases in cells further away from the joint, which are therefore more committed to terminal differentiation, and becomes almost undetectable in hypertrophic chondrocytes. In the newly formed bones, expression of Id2 is again abundant in osteoblasts.
DISCUSSION
In this study we report the use of random retroviral insertion to identify potential regulators of chondrocyte differentiation. Changes in chondrogenic phenotype were screened by Alcian Blue, a standard staining method to detect the existence of cartilaginous matrix. The feasibility of this strategy was confirmed by our identification of Id2 as an important regulator of chondrocyte differentiation. One limitation of this strategy is that retroviruses have a tendency to insert within actively transcribed regions of the genome [16] and therefore, retroviral insertion is less likely to target genes that are silenced in ATDC5 cells.
Id2 belongs to a subfamily of HLH proteins that include Id1, Id2, Id3 and Id4. These Id proteins all lack the DNA-binding domain and the founding member of this HLH subfamily, Id1, was named for its ability to function as both an inhibitor of DNA binding and an inhibitor of cell differentiation [17] . Of these four mammalian Id genes, Id1 and Id3 are expressed ubiquitously, whereas Id2 and Id4 exhibit a more restricted pattern of expression. It is not clear at the present time whether increased expression of other Id proteins is able to inhibit chondrocyte differentiation, or whether such an inhibitory function is unique to Id2 protein in chondrogenic cells.
Id2 protein can function as a dominant negative regulator of basic HLH proteins through the formation of a non-functional Id2-bHLH heterodimer. In this study we showed that Id2 inhibition of ATDC5 chondrogenic differentiation is manifested by repression of collagen genes such COL2. How is this achieved? One possibility is that certain HLH proteins are positive regulators of chondrogenic differentiation, and that Id2 suppresses expression of collagen genes by dimerizing with these basic HLH proteins. Another possibility is that Id2 over-expression leads to de-differentiation of ATDC5-derived cells and alteration in signal transduction. This is supported by the fact that these cells grow faster but do not possess the ability to undergo chondrogenic differentiation when cultured in insulin-containing medium.
Insulin treatment of ATDC5 cells increases the levels of both Id2 and Sox9 proteins. Sox9 is a master regulator of chondrocyte differentiation [14] and its expression is required for commitment and differentiation of mesenchymal cells towards the chondrogenic lineage in all developing skeletal elements [14] . Heterozygous mutations in and around the Sox9 gene result in haploinsufficiency and causes camptomelic dysplasia [18, 19] , a severe form of chondrodysplasia in human. Since insulin signalling affects many transcription factors that can regulate expression of Id2 and/or Sox9, we specifically knocked down Id2 by siRNA in ATDC5 cells and found that a decrease in Id2 expression is associated with an increase in Sox9 protein. While it is clear that Id2 can be a negative regulator of Sox9 expression in ATDC5 cells, over-expression of Id2 is also associated with an increased basal level of Sox9. Thus, the relationship between Id2 and Sox9 appears to be complex and may be dependent on the differentiation status of cells and the presence or absence of active signaling by growth factors.
Sox9 is known to transactivate expression of matrix genes such as COL2 in chondrocytes. In ATDC5-derived cells that over-express Id2, the basal level of Sox9 protein is higher but the basal level of COL2 is lower in comparison with those in ATDC5 cells. This observation supports the notion that Id2 over-expression leads to de-differentiation of ATDC5 chondroprogenitors and forces these cells to a more primitive stage that is not chondrogenic. In this primitive state, a higher basal level of Sox9 alone is not sufficient to increase COL2 expression. In addition, insulin signalling in these de-differentiated cells has also been altered and is no longer geared toward chondrogenic differentiation.
We also found that a modest increase in Id2 protein levels could have a dramatic effect on the proliferation of ATDC5-derived cells. Therefore, Id2 may also block expression of terminal differentiation-specific genes by diverting cells into S-phase of the cell cycle [5, 6] . It has been known for some time that Id2 protein can bind to the pRb (retinoblastoma protein) tumour suppressor and the related 'pocket proteins' p107 and p130 in vitro [20, 21] . A clear genetic interaction between Id2 and pRb has also been established because loss of Id2 partially rescues the pRb −/− lethal phenotype [22] . Id2 also prevents activation of p57 Kip2 , an important negative regulator of the cell cycle, and this inhibition is counteracted by pRb [23] . As pRb and the related 'pocket proteins' are crucial negative regulators of the cell cycle, an oversupply of Id2 protein in ATDC5 chondroprogenitor cells will likely result in sequestration of all three pocket proteins, leading to rapid progression of the cell cycle and a loss of the ability to undergo differentiation.
In ATDC5 cells, hypertrophic differentiation is accompanied by a decrease in Id2 protein. Our hypothesis that Id2 over-expression promotes de-differentiation and inhibits terminal differentiation is further supported by our immunohistostaining of growth plates in mouse E16.5 embryos: while Id2 protein is expressed in articular chondrocytes and proliferating chondrocytes near the epiphysis, its level decreases in chondrocyes closer to the hypertrophic zone and becomes almost undetectable in terminally differentiated hypertrophic chondrocytes. It has been known for some time that Id2 is indispensable for normal development, and Id2 knockout in mice results in retarded growth [8] . As expression of Id2 can be either up-or down-regulated in response to mitogen/growth factors in most cell types, our results raise the possibility that Id2 could be a critical down-stream target of multiple signalling pathways in chondrocytes to achieve a fine balance between growth and differentiation during chondrogenesis.
